Home

Antisense Oligonucletide (ASO) Employers

Companies working with Antisense Oligonucletide (ASO) also work in 16 other areas:

The number of employers follows the core activity.

9 Employers in 13 Locations

Biogen

Description: 

Biogen discovers, develops and manufactures therapies for serious neurological diseases. ...

Creyon Bio

Description: 

Creyon Bio is taking an engineering approach to creating new ...

Flamingo Therapeutics

Description: 

Flamingo has a late-stage pipeline focused RNA-targeting antisense oligonucleotides to ...

Haya Therapeutics

Description: 

HAYA Therapeutics is a precision therapeutics company that discovers and ...

Ionis Pharmaceuticals

Description: 

Ionis makes antisense oligonucletides that target mRNA molecules that code ...

PepGen

Description: 

PepGen uses their Enhanced Delivery Oligonucleotide technology to solve ...

Sarepta Therapeutics

Description: 

Sarepta Therapeutics is a biopharmaceutical company focused on developing innovative ...

Stoke Therapeutics

Description: 

Stoke is developing antisense oligonucleotide medicines that target RNA splicing ...

Switch Therapeutics

Description: 

Switch’s Conditionally Activated siRNA (CASi), developed at Caltech, Harvard Medical ...

Don't see an employer? Please fill out the form